![]() |
|
|
Vol. 304, Issue 1, 15-21, January 2003
Yerkes Regional Primate Research Center, Emory University, Atlanta,
Georgia (H.L.K., M.J.K.), and Research Triangle Institute, Research
Triangle Park, North Carolina (F.I.C.)
Several studies have shown that repeated cocaine administration,
followed by withdrawal, alters dopamine transporter (DAT) levels in the
rat. These changes must arise from changes in either transporter
protein production or degradation, or both. Previously, our laboratory
developed an approach to measure the synthesis rate, degradation rate
constant, and half-life of DAT in the rat striatum and nucleus
accumbens after administration of the irreversible dopamine transporter
ligand, RTI-76
[3
-(3-p-chlorophenyl)tropan-2
-carboxylic acid
p-isothiocyanatophenylethyl ester hydrochloride].
Transporter binding was measured with [3H]GBR12935
[1-(2-[diphenylmethoxy]ethyl)-4-[3-phenylpropyl]piperazine]. These initial studies showed that: 1) the half-life of the transporter was between 2 and 3 days in these two brain regions; 2) pretreatment with dopamine D1 and D2 receptor agonists and antagonists over several
days differentially altered DAT half-lives in the striatum and nucleus
accumbens; and 3) pretreatment with cocaine for several days increased
the half-life of DAT by decreasing the degradation rate constant in
both brain regions. In the present study, we determined that repeated
pretreatment (10 days) with 20 mg/kg cocaine (i.p.) and a subsequent
withdrawal period (10 days) alters the dopamine transporter turnover in
the rat striatum, but not in the nucleus accumbens. Cocaine
pretreatment and withdrawal reduced the half-life of the transporter
protein from 2.1 days to 0.94 day in the striatum, but did not alter
the half-life of 2.2 days in the nucleus accumbens. The results
indicate the complex and long-lasting effects of cocaine administration
on cellular processes. The mechanism(s) of these effects remains to be elucidated.